Barclays PLC grew its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 32.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 146,208 shares of the company's stock after purchasing an additional 36,189 shares during the period. Barclays PLC owned 0.16% of Acadia Healthcare worth $5,796,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of ACHC. Wellington Management Group LLP raised its stake in Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after acquiring an additional 76,490 shares during the period. FMR LLC grew its holdings in shares of Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. Stephens Investment Management Group LLC lifted its holdings in shares of Acadia Healthcare by 24.9% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company's stock worth $58,490,000 after purchasing an additional 294,210 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Acadia Healthcare by 9.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,234,223 shares of the company's stock valued at $48,937,000 after purchasing an additional 107,162 shares during the period.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on ACHC shares. KeyCorp dropped their target price on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. TD Cowen dropped their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $43.00 to $35.00 in a research note on Friday, February 28th. Mizuho dropped their price target on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 25th. Finally, Bank of America cut their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $50.39.
Read Our Latest Research Report on ACHC
Acadia Healthcare Price Performance
Shares of ACHC stock traded up $0.17 during midday trading on Tuesday, reaching $22.35. 2,632,653 shares of the company were exchanged, compared to its average volume of 1,593,246. The company's 50 day moving average price is $29.04 and its two-hundred day moving average price is $38.27. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market cap of $2.06 billion, a P/E ratio of 7.33, a PEG ratio of 1.46 and a beta of 1.13. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.